 WIXOM, Mich., Jan. 05, 2021 GLOBE NEWSWIRE -- Rockwell Medical, Inc. Nasdaq: RMTI Rockwell Medical or the Company, a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and iron deficiency anemia management and improving outcomes for patients around the world, today announced the Rockwell Medical executive management team will record a presentation at H.C. Wainwright BioConnect 2021 Conference. This presentation will become publicly available on January 11, 2021, at 6:00 a.m. ET and will be archived for 30 days thereafter, via the Companys website at under the Investors section. 